Carrier Erythrocytes

[1]  M. Magnani,et al.  Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Fielding.  Liposomal Drug Delivery , 1991, Clinical pharmacokinetics.

[3]  E. Zocchi,et al.  Liver targeting of autologous erythrocytes loaded with doxorubicin. , 1991, European journal of cancer.

[4]  M. Magnani,et al.  Human red blood cells as bioreactors for the release of 2',3'-dideoxycytidine, an inhibitor of HIV infectivity. , 1989, Biochemical and biophysical research communications.

[5]  E. Zocchi,et al.  Encapsulation of doxorubicin in liver-targeted erythrocytes increases the therapeutic index of the drug in a murine metastatic model. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[6]  E. Zocchi,et al.  Conversion of encapsulated 5-fluoro-2'-deoxyuridine 5'-monophosphate to the antineoplastic drug 5-fluoro-2'-deoxyuridine in human erythrocytes. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Nicolau,et al.  Long-term physiological effects of enhanced O2 release by inositol hexaphosphate-loaded erythrocytes. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[8]  E. Zocchi,et al.  Encapsulation of adriamycin in human erythrocytes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[9]  J. Deloach,et al.  Hepatic pharmacokinetics of glutaraldehyde-treated methotrexate-loaded carrier erythrocytes in dogs , 1983, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.

[10]  N. Peppas,et al.  Present and future applications of biomaterials in controlled drug delivery systems. , 1981, Biomaterials.

[11]  A. De Flora,et al.  In vitro correction of erythrocyte glucose 6-phosphate dehydrogenase (G6PD) deficiency. , 1979, Archives of biochemistry and biophysics.

[12]  E. Beutler,et al.  Enzyme replacement therapy in Gaucher's disease: preliminary clinical trial of a new enzyme preparation. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[13]  T. Tsong,et al.  Formation and resealing of pores of controlled sizes in human erythrocyte membrane , 1977, Nature.

[14]  S. Peters,et al.  Effect of glutaraldehyde treatment on enzyme-loaded erythrocytes. , 1977, Biochimica et biophysica acta.

[15]  J. Hoffman.  PHYSIOLOGICAL CHARACTERISTICS OF HUMAN RED BLOOD CELL GHOSTS , 1958, The Journal of general physiology.